3.0
Dec 4, 2025
Former employee, more than 1 year
London, England
Recommend
CEO approval
Business Outlook
Pros
Great pipeline of biosimilars Competitively priced, providing savings and value to NHS Some talented and experienced colleagues
Cons
Hire & fire with blame culture with high staff turnover South Korean HQ involved in all aspects of UK affairs and require approval Does not respect the industry code of practice Senior management are unprofessional Pressurise sales force to follow unreasonable requests e.g. contact HCPs without consent